Glaukos Corporation (NYSE: GKOS)
Health Care · Health Care Equipment & Supplies · US
$181.39
-1.89% today · +96.4% 1Y
Glaukos Corporation (NYSE: GKOS) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $10.90B and employs 1,094 people.
Over the last twelve months the share price has gained 96.4%, trading between 73.16 and 191.62.
Tweenvest scores Glaukos Corporation across four factors: quality 62/100, value 34/100, growth 92/100. Its strongest factor is growth.
GKOS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.90B
- Revenue (TTM)
- $612.84M
- P/E
- —
- EPS
- -3.25
- Dividend yield
- —
- Beta (5Y)
- 0.76
- 52-week high
- $191.62
- 52-week low
- $73.16
- Avg volume (3M)
- —
- Shares outstanding
- 58.96M
- Employees
- 1,094
- Next earnings
- —
About Glaukos Corporation
Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
- ISIN
- US3773221029
- Founded
- 1998
- Listed since
- Jun 25, 2015
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.13 | -0.46% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.84 | -0.46% |
| Stryker CorporationNYSE: SYK | $126.81B | $330.59 | +0.85% |
| Medtronic plcNYSE: MDT | $116.66B | $91.14 | -1.89% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €159.15 | -1.58% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $49.86 | +1.73% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.